Literature DB >> 21824272

Oncogenes induce senescence with incomplete growth arrest and suppress the DNA damage response in immortalized cells.

Michael Y Sherman1, Le Meng, Martha Stampfer, Vladimir L Gabai, Julia A Yaglom.   

Abstract

Activation of the Her2 (ErbB2) oncogene is implicated in the development of breast, ovary and other cancers. Here, we show that expression of NeuT, a mutant-activated rodent isoform of Her2, in immortalized breast epithelial cells, while promoting senescence-associated morphological changes, up-regulation of senescence-associated β-galactosidase activity, and accumulation of the cyclin-dependent kinase inhibitor p21, failed to trigger the major senescence end-point, i.e. permanent growth arrest. Similar senescence-associated phenotype with incomplete growth arrest, which we dubbed senescence with incomplete growth arrest (SWING), could also be triggered by the expression of the Ras oncogene. SWING phenotype was stable, and persisted in tumor xenografts established from NeuT-transduced cells. Furthermore, a significant population of cells in SWING state was found in tumors in the MMTV/NeuT transgenic mouse model. SWING cells showed downregulation of histone H2AX, critical for repair of double-stranded DNA breaks, and impaired activation of Chk1 kinase. Overall, SWING cells were characterized by increased DNA instability and hypersensitivity to genotoxic stresses. We propose that the SWING state could be a stage in the process of cancer development.
© 2011 The Authors. Aging Cell © 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824272      PMCID: PMC3433764          DOI: 10.1111/j.1474-9726.2011.00736.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  50 in total

1.  Extension of life-span by introduction of telomerase into normal human cells.

Authors:  A G Bodnar; M Ouellette; M Frolkis; S E Holt; C P Chiu; G B Morin; C B Harley; J W Shay; S Lichtsteiner; W E Wright
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

2.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

3.  TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells.

Authors:  Rocky Cipriano; Charlene E Kan; James Graham; David Danielpour; Martha Stampfer; Mark W Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

4.  A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.

Authors:  Clemens A Schmitt; Jordan S Fridman; Meng Yang; Soyoung Lee; Eugene Baranov; Robert M Hoffman; Scott W Lowe
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

5.  Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor beta growth inhibition in p16INK4A(-) human mammary epithelial cells.

Authors:  M R Stampfer; J Garbe; G Levine; S Lichtsteiner; A P Vasserot; P Yaswen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

Review 6.  Jailbreak: oncogene-induced senescence and its evasion.

Authors:  Fiona K E McDuff; Suzanne D Turner
Journal:  Cell Signal       Date:  2010-07-13       Impact factor: 4.315

7.  High frequency of BRAF mutations in nevi.

Authors:  Pamela M Pollock; Ursula L Harper; Katherine S Hansen; Laura M Yudt; Mitchell Stark; Christiane M Robbins; Tracy Y Moses; Galen Hostetter; Urs Wagner; John Kakareka; Ghadi Salem; Tom Pohida; Peter Heenan; Paul Duray; Olli Kallioniemi; Nicholas K Hayward; Jeffrey M Trent; Paul S Meltzer
Journal:  Nat Genet       Date:  2002-11-25       Impact factor: 38.330

8.  Senescence of human fibroblasts induced by oncogenic Raf.

Authors:  J Zhu; D Woods; M McMahon; J M Bishop
Journal:  Genes Dev       Date:  1998-10-01       Impact factor: 11.361

9.  Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion.

Authors:  Catherine L Olsen; Betty Gardie; Paul Yaswen; Martha R Stampfer
Journal:  Oncogene       Date:  2002-09-12       Impact factor: 9.867

10.  Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation.

Authors:  A J Brenner; M R Stampfer; C M Aldaz
Journal:  Oncogene       Date:  1998-07-16       Impact factor: 9.867

View more
  21 in total

1.  Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.

Authors:  Thomas Clozel; ShaoNing Yang; Rebecca L Elstrom; Wayne Tam; Peter Martin; Matthias Kormaksson; Samprit Banerjee; Aparna Vasanthakumar; Biljana Culjkovic; David W Scott; Sarah Wyman; Micheal Leser; Rita Shaknovich; Amy Chadburn; Fabrizio Tabbo; Lucy A Godley; Randy D Gascoyne; Katherine L Borden; Giorgio Inghirami; John P Leonard; Ari Melnick; Leandro Cerchietti
Journal:  Cancer Discov       Date:  2013-08-16       Impact factor: 39.397

2.  Epigenetic approaches for chemosensitization of refractory diffuse large B-cell lymphomas.

Authors:  James J Steinhardt; Ronald B Gartenhaus
Journal:  Cancer Discov       Date:  2013-09       Impact factor: 39.397

3.  HSF1, a versatile factor in tumorogenesis.

Authors:  S K Calderwood
Journal:  Curr Mol Med       Date:  2012-11-01       Impact factor: 2.222

4.  The Damaging Effect of Passenger Mutations on Cancer Progression.

Authors:  Christopher D McFarland; Julia A Yaglom; Jonathan W Wojtkowiak; Jacob G Scott; David L Morse; Michael Y Sherman; Leonid A Mirny
Journal:  Cancer Res       Date:  2017-05-23       Impact factor: 12.701

Review 5.  Molecular chaperones in mammary cancer growth and breast tumor therapy.

Authors:  Stuart K Calderwood; Jianlin Gong
Journal:  J Cell Biochem       Date:  2012-04       Impact factor: 4.429

6.  Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells.

Authors:  Paul L Severson; Lukas Vrba; Martha R Stampfer; Bernard W Futscher
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2014-11-04       Impact factor: 2.873

7.  Disentangling the aneuploidy and senescence paradoxes: a study of triploid breast cancers non-responsive to neoadjuvant therapy.

Authors:  B I Gerashchenko; K Salmina; J Eglitis; A Huna; V Grjunberga; J Erenpreisa
Journal:  Histochem Cell Biol       Date:  2016-02-09       Impact factor: 4.304

Review 8.  Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.

Authors:  Daniel R Ciocca; Andre Patrick Arrigo; Stuart K Calderwood
Journal:  Arch Toxicol       Date:  2012-08-11       Impact factor: 5.153

9.  Aging phenotypes in cultured normal human mammary epithelial cells are correlated with decreased telomerase activity independent of telomere length.

Authors:  Klara Sputova; James C Garbe; Fanny A Pelissier; Eric Chang; Martha R Stampfer; Mark A LaBarge
Journal:  Genome Integr       Date:  2013-05-29

10.  Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions.

Authors:  Anitha Suram; Jessica Kaplunov; Priyanka L Patel; Haihe Ruan; Aurora Cerutti; Virginia Boccardi; Marzia Fumagalli; Raffaella Di Micco; Neena Mirani; Resham Lal Gurung; Manoor Prakash Hande; Fabrizio d'Adda di Fagagna; Utz Herbig
Journal:  EMBO J       Date:  2012-05-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.